---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-21-042603"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2021-12-21T23:59:59+00:00"
generated_at: "2026-06-27T23:30:37.526158+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Luba Greenwood resigns from Brooklyn ImmunoTherapeutics board effective Jan 1, 2022

## Summary
- Luba Greenwood notified board on Dec 16, 2021, of her resignation as director effective Jan 1, 2022.
- Resignation not due to any disagreement with the company’s operations, policies, or practices.
- No replacement has been announced as of the filing date.

## SEC filing metadata
- accession: 0001140361-21-042603
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2021-12-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036121042603/0001140361-21-042603-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036121042603/brhc10032107_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-21-042603
- JSON: https://secwatch.observer/filing/0001140361-21-042603.json
- Plain text: https://secwatch.observer/filing/0001140361-21-042603.txt

## Key facts
- Executive change
  Luba Greenwood resigned as Director at Ernexa Therapeutics Inc..
  - Action: resigned
  - Role: Director
  source text: On December 16, 2021, Luba Greenwood notified the board of directors of her intention to resign as a director effective as of January 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036121042603/0001140361-21-042603-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.